RT Journal Article
SR Electronic
T1 Low rate of daily smokers in patients with symptomatic COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.10.20127514
DO 10.1101/2020.06.10.20127514
A1 Miyara, Makoto
A1 Tubach, Florence
A1 Pourcher, Valérie
A1 Morélot-Panzini, Capucine
A1 Pernet, Julie
A1 Haroche, Julien
A1 Lebbah, Said
A1 Morawiec, Elise
A1 Gorochov, Guy
A1 Caumes, Eric
A1 Hausfater, Pierre
A1 Combes, Alain
A1 Similowski, Thomas
A1 Amoura, Zahir
YR 2020
UL http://medrxiv.org/content/early/2020/06/12/2020.06.10.20127514.abstract
AB Background Identification of prognostic factors in COVID-19 remains a global challenge. The role of smoking is still controversial.Objective To evaluate the rate of daily smokers in patients with COVID-19.Methods COVID-19 in-and outpatients from a large French university hospital were systematically interviewed for their smoking status, use of e-cigarette and nicotinic substitutes. The rates of daily smokers in in-and outpatients were compared to those in the 2019 French general population, after standardization for sex and age.Results The inpatient group was composed of 340 patients, median age 66 years: 203 men (59.7%) and 137 women (40.3%), median age for both 66 years, with a daily smokers rate of 4.1 % CI95% [2.3–6.9] (5.4% of men, 2.2% of women). The outpatient group was composed of 139 patients, median age 44 years: 62 men (44.6%, median age 43 years), and 77 women (55.4%, median age 44 years). The daily smoker rate was 6.1 % CI 95% [2.7 - 11.6] (5.1% of men, 6.8% of women). In the 2019 French population, the daily smoker rate was 24.0% (27.5% of men, 20.7% of women). Among inpatients, daily smokers represented 2.2% and 3.4% of the 45 dead patients and of the 29 patients transferred to ICU, respectively.The rate of daily smokers was significantly lower in COVID-19 patients, as compared to that in the French general population after standardization by age and sex, with Standardized Incidence Ratios of 0.24 [0.12-0.48] for outpatients and 0.24 [0.14-0.40] for inpatients.Conclusion Daily smokers rate in patients with symptomatic COVID-19 is lower as compared to the general populationCompeting Interest StatementThe authors have declared no competing interest.Funding Statementnot applicableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has been approved by the ethics committee of Sorbonne University (2020 - CER-2020-13).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available upon resquest to the corresponding author